Is IKNA or RYLD a better dividend investment in 2026?

IKNA currently yields 11.66% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between IKNA and RYLD?

IKNA has a forward dividend yield of 11.66% ($2.00/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 0.48 percentage points.

Home › Compare › IKNA vs RYLD

IKNA vs RYLD: Dividend Comparison 2026

IKNA yields 11.66% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $1.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

IKNA

● Live price

11.66%

Share price

$17.16

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$43.2K

Annual income

$2,414.13

Full IKNA calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — IKNA vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IKNA	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IKNA + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IKNA pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IKNA

Annual income on $10K today (after 15% tax)

$990.68/yr

After 10yr DRIP, annual income (after tax)

$2,052.01/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RYLD beats the other by $147.24/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IKNA + RYLD for your $10,000?

IKNA: 50%RYLD: 50%

100% RYLD50/50100% IKNA

Portfolio after 10yr

$43.8K

Annual income

$2,500.73/yr

Blended yield

5.70%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on IKNA right now

IKNA

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$1.33

-92.2% upside vs current

Range: $1.33 — $1.33

Altman Z

60.4

Piotroski

2/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IKNA buys

RYLD buys

No recent congressional trades found for IKNA or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIKNARYLD

Forward yield	11.66%	12.14% ✓
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$43.2K	$44.5K ✓
Annual income after 10y	$2,414.13	$2,587.35 ✓
Total dividends collected	$17.8K	$18.8K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: IKNA vs RYLD ($10,000, DRIP)

Year	IKNA Portfolio	IKNA Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$11,866	$1,165.50	$11,914	$1,213.65	$48.00 → RYLD
2	$13,989	$1,292.45	$14,099	$1,351.30	$110.00 → RYLD
3	$16,392	$1,424.02	$16,580	$1,494.55	$188.00 → RYLD
4	$19,099	$1,559.51	$19,384	$1,642.61	$285.00 → RYLD
5	$22,134	$1,698.17	$22,535	$1,794.70	$401.00 → RYLD
6	$25,522	$1,839.29	$26,063	$1,950.00	$541.00 → RYLD
7	$29,291	$1,982.13	$29,995	$2,107.69	$704.00 → RYLD
8	$33,467	$2,125.99	$34,361	$2,266.99	$894.00 → RYLD
9	$38,080	$2,270.21	$39,194	$2,427.12	$1.1K → RYLD
10	$43,160	$2,414.13	$44,525	$2,587.35	$1.4K → RYLD

IKNA vs RYLD: Complete Analysis 2026

IKNA — Stock

Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.

Full IKNA Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this IKNA vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IKNA vs SCHD IKNA vs JEPI IKNA vs O IKNA vs KO IKNA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.